A Study of Arzoxifene to Treat Korean Women With Osteoporosis

NCT00767299 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: arzoxifene
DRUG: Placebo

Sponsor

Eli Lilly and Company